Infectious disease and women's health:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Saunders
2003
|
| Schriftenreihe: | Obstetrics and gynecology clinics of North America
30,4 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII S., S. 623 - 837 Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV017771139 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 040113s2003 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)53964830 | ||
| 035 | |a (DE-599)BVBBV017771139 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-578 | ||
| 050 | 0 | |a RG1.C5 v.30 no.4 | |
| 245 | 1 | 0 | |a Infectious disease and women's health |c Lisa M. Hollier ... guest ed. |
| 264 | 1 | |a Philadelphia [u.a.] |b Saunders |c 2003 | |
| 300 | |a XIII S., S. 623 - 837 |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Obstetrics and gynecology clinics of North America |v 30,4 | |
| 650 | 7 | |a Infectieziekten |2 gtt | |
| 650 | 7 | |a Seksueel overdraagbare aandoeningen |2 gtt | |
| 650 | 4 | |a Chlamydia infections |x Diagnosis | |
| 650 | 4 | |a Communicable Diseases | |
| 650 | 4 | |a Papillomavirus | |
| 650 | 4 | |a Sexually Transmitted Diseases | |
| 650 | 4 | |a Sexually transmitted diseases | |
| 650 | 4 | |a Women's Health | |
| 700 | 1 | |a Hollier, Lisa M. |e Sonstige |4 oth | |
| 830 | 0 | |a Obstetrics and gynecology clinics of North America |v 30,4 |w (DE-604)BV000617486 |9 30,4 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010672881&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-010672881 | ||
Datensatz im Suchindex
| _version_ | 1804130477293961219 |
|---|---|
| adam_text | IN! K IRU.S DisKASI 1 ¦ IU »MI:,V * HI AI 1M
CONTENTS
Preface xi
Lisa M. Hollier and George D. Wendel, Jr
Maternal Immunization 623
Stanley A. Gall
Maternal immunization embraces the concepts that vaccines given to
pregnant women enhance their resistance to vaccine preventable
diseases and passive antibodies that cross the placenta protect the
neonate for the first 3 to 6 months of life. It is a great public health
move to get excellent protection at a small cost. Because all recom¬
mended vaccines for use in pregnancy are safe, it makes good sense
to bring patients up to date on vaccines.
Developments in the Screening for Chlamydia trachomatis:
A Review 637
Katrin S. Kohl, Lauri E. Markowitz, and Emilia H. Koumans
Screening for Chlntm/dia trachomatis infection remains an essential
component of C trachomatis control. It is cost effective, most infections
are asymptomatic, and symptom based health care seeking and test¬
ing identify few infected individuals. Most studies and all guidelines
recommend that all women aged 25 be screened yearly for
C trachomatis infection. The number of sex partners, new or more
than one sex partners, and previous infection may serve as criteria for
screening women aged 25. Because re infection rates are high and
occur within a few months, ensuring that partners are treated and
screening women four to six months after initial infection may fur¬
ther reduce complications.
VOLUME 30 • NUMBER 4 • DECEMBER 2003 v
Behavioral Interventions for Prevention of Sexually Transmitted
Diseases in Women: A Physician s Perspective 659
Jeanna M. Piper, Rochelle N. Shain, Jeffrey E. Korte, and
Alan E. C. Holden
Behavioral interventions can encourage women to make life
changes that result in reduced risk of acquiring sexually transmit¬
ted diseases. Some of the successful interventions have been made
available for public implementation, whereas others are still limited
to the research setting. Until public behavioral interventions are
more readily accessible, physicians can incorporate aspects
of intervention into their daily practice to assist female patients in
improving their sexual health.
Vulvovaginal Candidiasis 671
Paul Nyirjesy and Jack D. Sobel
Vulvovaginal candidiasis is a common disorder that affects mil¬
lions of women. For therapeutic purposes, patients with vulvo¬
vaginal candidiasis should be classified as having complicated or
uncomplicated disease. Various host factors, including genetic,
biologic, and behavioral, can affect host colonization with yeast
species and transformation to symptomatic infection. Treatment
should be individualized to each patient s circumstances.
Although there is a clear need for better use of diagnostic modali¬
ties and development of better treatment alternatives, most
patients with vulvovaginal candidiasis at least have the perspec¬
tive of achieving adequate control of their symptoms. Future
advances, particularly in the area of home diagnostics, may help to
optimize use of currently available medicines.
Gynecologic Consequences of Bacterial Vaginosis 685
Jane R. Schwebke
Bacterial vaginosis is the most prevalent cause of symptomatic
vaginitis in sexually active women. It is linked to several gyneco¬
logic complications, acquisition of sexually transmitted diseases,
and acquisition and transmission of HIV. The decrease in the num¬
ber of hydrogen peroxide producing lactobacilli is hypothesized
to be a major factor in the development of complications associated
with bacterial vaginosis. The large numbers of anaerobic bacteria
present in the vagina in women with bacterial vaginosis likely con¬
tribute to the overall risk of infectious complications after instru¬
mentation of the upper genital tract. Normalization of the vaginal
flora may be effective for preventing short term complications. The
implications of screening and treating bacterial vaginosis to pre¬
vent long term complications are less clear and may depend on the
availability of more effective treatment regimens.
vi CONTENTS
Critical Care Infectious Disease 695
Julie A. Gainer and Nicole P. Yost
Septic shock, toxic shock syndrome, acute respiratory distress syn¬
drome, and catheter related infections are conditions in which
intensive care management of the patient may be necessary. Toxic
shock syndrome is a toxin mediated illness that is not limited to
young menstruating women and should be considered in women
and men who present with fever, hypotension, rash, and multi
organ dysfunction. Sepsis is the leading cause of death in
critically ill patients in the United States and is the most common
predisposing factor for acute lung injury or acute respiratory dis¬
tress syndrome. Central venous catheters are often a necessity for
optimal patient care in these critically ill patients.
Gynecologic Issues in the HIV Infected Woman 711
Helen E. Cejtin
In this article, gynecologic conditions of increased importance in
HIV infected women are discussed. HIV positive women may
have an increase in menstrual disorders, and they are more likely
to have lower genital tract neoplasia and sexually transmitted
infections. The literature relevant to choosing a method of contra¬
ception for HIV positive women also is discussed.
Antiviral and Antiretroviral Use in Pregnancy 731
Deborah M. Money
The history of antiviral and antiretroviral therapy is recent compared
with many other medical therapies, including traditional antibiotics
in pregnancy. There are few long term data on which to base deci¬
sions of management in pregnancy. Accessing up to date informa¬
tion is critical to optimizing the safety of care for mothers and their
infants. Exposure to medications in pregnancy can be toxic to a fetus
in a gestational age dependent manner. Determination of safe med¬
ications for pregnancy must take into consideration the need for cer¬
tain medications and the possibility of inadvertent exposure in early
pregnancy because of unplanned pregnancies. This article reviews
the most commonly used antiviral and antiretroviral agents and
places emphasis on the issues regarding use in pregnancy.
Treatment of Sexually Transmitted Diseases in Women 751
Lisa M. Hollier and Kimberly Workovvski
Guidelines for the treatment of patients with sexually transmitted
infection are developed by the Centers for Disease Control and
Prevention after consultation with a group of professionals knowl¬
edgeable in the field. This article briefly introduces various infec¬
tions, reviews new diagnostic information, and presents the latest
guidelines for therapy. All recommended and alternative regimens
are drawn from the most recent treatment guidelines. Although this
CONTENTS vii
article focuses primarily on therapy, it also emphasizes the impor¬
tance of counseling and prevention. Clinicians have the opportunity
and obligation to provide education and counseling to patients.
Prevention messages should be tailored to the individual patient
with consideration given to her specific risk behaviors.
Pelvic Inflammatory Disease: New Diagnostic Criteria
and Treatment 777
Richard H. Beigi and Harold C. Wiesenfeld
Pelvic inflammatory disease (PID) is a common disease that affects
women of reproductive age and presents an enormous public
health and economic burden. It is responsible for much short and
long term morbidity that may necessitate interventions subse¬
quent to the original infection. Mild PID seems to be much more
common than severe or classic PID, and the importance of early
recognition and treatment cannot be understated. Current treat¬
ment regimens seem to be effective in terms of immediate clinical
efficacy. Research into less clinically severe or subclinical PID is
beginning to uncover the true burden of disease among women.
Insights into newer diagnostic techniques and subclinical PID and
updated treatment regimens are presented.
Sexually Transmitted Infections and Contraceptives:
Selective Issues 795
Gretchen S. Stuart and Paula M. Castano
There is a complicated relationship between contraceptives and
sexually transmitted infections. In this article on current literature,
topics such as the intrauterine device and pelvic inflammatory dis¬
ease, the intrauterine device and HIV, and hormonal contracep¬
tives and sexually transmitted diseases are presented.
Human Papillomavirus Infections: Diagnosis, Treatment, and
Hope for a Vaccine 809
Kevin A. Ault
This article reviews the epidemiology, transmission, diagnosis, and
treatment of human papillomavirus infections. Progress toward pre¬
ventive and therapeutic human papillomavirus vaccines also is
reviewed. Gynecologists should know that human papillomavirus is
the most common sexually transmitted infection, and they should be
familiar with potential treatments for external genital warts, a
sequela of human papillomavirus infection.
Cumulative Index 2003 819
Statement of Ownership
Subscription Information
viii CONTENTS
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV017771139 |
| callnumber-first | R - Medicine |
| callnumber-label | RG1 |
| callnumber-raw | RG1.C5 v.30 no.4 |
| callnumber-search | RG1.C5 v.30 no.4 |
| callnumber-sort | RG 11 C5 V 230 NO 14 |
| callnumber-subject | RG - Gynecology and Obstetrics |
| ctrlnum | (OCoLC)53964830 (DE-599)BVBBV017771139 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01494nam a2200385 cb4500</leader><controlfield tag="001">BV017771139</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">040113s2003 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)53964830</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV017771139</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RG1.C5 v.30 no.4</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Infectious disease and women's health</subfield><subfield code="c">Lisa M. Hollier ... guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII S., S. 623 - 837</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Obstetrics and gynecology clinics of North America</subfield><subfield code="v">30,4</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infectieziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Seksueel overdraagbare aandoeningen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chlamydia infections</subfield><subfield code="x">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Papillomavirus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sexually Transmitted Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sexually transmitted diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Women's Health</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hollier, Lisa M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Obstetrics and gynecology clinics of North America</subfield><subfield code="v">30,4</subfield><subfield code="w">(DE-604)BV000617486</subfield><subfield code="9">30,4</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010672881&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010672881</subfield></datafield></record></collection> |
| id | DE-604.BV017771139 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:21:38Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010672881 |
| oclc_num | 53964830 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-578 |
| owner_facet | DE-19 DE-BY-UBM DE-578 |
| physical | XIII S., S. 623 - 837 Ill., graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Saunders |
| record_format | marc |
| series | Obstetrics and gynecology clinics of North America |
| series2 | Obstetrics and gynecology clinics of North America |
| spelling | Infectious disease and women's health Lisa M. Hollier ... guest ed. Philadelphia [u.a.] Saunders 2003 XIII S., S. 623 - 837 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Obstetrics and gynecology clinics of North America 30,4 Infectieziekten gtt Seksueel overdraagbare aandoeningen gtt Chlamydia infections Diagnosis Communicable Diseases Papillomavirus Sexually Transmitted Diseases Sexually transmitted diseases Women's Health Hollier, Lisa M. Sonstige oth Obstetrics and gynecology clinics of North America 30,4 (DE-604)BV000617486 30,4 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010672881&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Infectious disease and women's health Obstetrics and gynecology clinics of North America Infectieziekten gtt Seksueel overdraagbare aandoeningen gtt Chlamydia infections Diagnosis Communicable Diseases Papillomavirus Sexually Transmitted Diseases Sexually transmitted diseases Women's Health |
| title | Infectious disease and women's health |
| title_auth | Infectious disease and women's health |
| title_exact_search | Infectious disease and women's health |
| title_full | Infectious disease and women's health Lisa M. Hollier ... guest ed. |
| title_fullStr | Infectious disease and women's health Lisa M. Hollier ... guest ed. |
| title_full_unstemmed | Infectious disease and women's health Lisa M. Hollier ... guest ed. |
| title_short | Infectious disease and women's health |
| title_sort | infectious disease and women s health |
| topic | Infectieziekten gtt Seksueel overdraagbare aandoeningen gtt Chlamydia infections Diagnosis Communicable Diseases Papillomavirus Sexually Transmitted Diseases Sexually transmitted diseases Women's Health |
| topic_facet | Infectieziekten Seksueel overdraagbare aandoeningen Chlamydia infections Diagnosis Communicable Diseases Papillomavirus Sexually Transmitted Diseases Sexually transmitted diseases Women's Health |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010672881&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000617486 |
| work_keys_str_mv | AT hollierlisam infectiousdiseaseandwomenshealth |